
Centre Hospitalier Universitaire de Limoges
Centre Hospitalier Universitaire de Limoges
Funder
45 Projects, page 1 of 9
assignment_turned_in Project2013 - 2016Partners:Centre Hospitalier Universitaire de LimogesCentre Hospitalier Universitaire de LimogesFunder: Institut National du Cancer Project Code: INCa-7534more_vert assignment_turned_in ProjectFrom 2021Partners:INRAE, Centre Hospitalier Universitaire de Limoges, Institut Pasteur, François Rabelais University, INSERM +4 partnersINRAE,Centre Hospitalier Universitaire de Limoges,Institut Pasteur,François Rabelais University,INSERM,Infectiologie Animale et Sante Publique,ANTI-INFECTIEUX : SUPPORTS MOLÉCULAIRES DES RÉSISTANCES ET INNOVATIONS THÉRAPEUTIQUES,University of Limoges,ANSES - Laboratoire de LyonFunder: French National Research Agency (ANR) Project Code: ANR-20-CE35-0011Funder Contribution: 410,119 EURThe worldwide emergence of antimicrobial resistant (AMR) bacteria relies on both the ability of mobile genetic elements (MGEs) to spread antibiotic resistance genes (ARGs), and the capacity of successful clones to disseminate. Evidence for the environmental origin of AMR in human and veterinary clinics highlights the mandate for the surveillance of emerging AMR. The objective of the PRE-EMPT project is to identify, and quantify the reservoir of mobile ARGs in different environments, and characterize the potential of these genes to be transferred to pathogens by combining high-throughput based techniques connecting the genes, the MGEs, and the bacterial communities. We will target three environmental sites, from urban, animal and littoral contexts, combine metagenomic techniques with enrichment methods (targeted PCR, hybridization capture, Hi-C), characterize the functional properties of the identified ARGs, and evaluate the dissemination of these ARGs in bacterial communities
more_vert assignment_turned_in ProjectPartners:HUG, Groupe Hospitalier Henri Mondor - Albert Chenevier, CHU, Hôpital Claude Huriez, CHRU MTP +10 partnersHUG,Groupe Hospitalier Henri Mondor - Albert Chenevier,CHU,Hôpital Claude Huriez,CHRU MTP,Hôpital Necker- Enfants malades,Centre Hospitalier Universitaire de Limoges,CHU Nantes - Hôtel Dieu,Centre Hospitalier Universitaire de Poitiers,Centre Hospitalier Universitaire de Toulouse,Institut de cancérologie Lucien Neuwirth,Institut Paoli-Calmettes- (IPC),HUS,HCL,Groupe Hospitalier Pitié SalpétrièreFunder: Institut National du Cancer Project Code: INCa-DGOS-11089more_vert assignment_turned_in Project2014 - 2017Partners:Groupe Hospitalier Diaconesses Croix Saint Simon, Hôpital Claude Huriez, Institut Gustave Roussy, Centre Hospitalier Universitaire de La Réunion, Centre Léon Bérard +24 partnersGroupe Hospitalier Diaconesses Croix Saint Simon,Hôpital Claude Huriez,Institut Gustave Roussy,Centre Hospitalier Universitaire de La Réunion,Centre Léon Bérard,Institut Bergonié,Centre Hospitalier Universitaire de Reims,Hôpital Louis Mourier,Centre Hospitalier Universitaire de Saint-Étienne,Centre François Baclesse,Institut Paoli-Calmettes- (IPC),Hôpital Hôtel-Dieu,Centre Hospitalier Universitaire de Toulouse,Hôpital de l'Archet,Hôpital le Bocage,Institut de Cancérologie de Lorraine,HUS,ICM-VAL D'AURELLE,Centre Hospitalier Universitaire de Limoges,Institut Curie,CHU Marseille - Hôpital la Timone,Groupe Hospitalier Lariboisière - Fernand Widal,CHUG,CHUAP,Hôpital Tenon,HCL,Centre hospitalier universitaire de Poitie,Institut de Cancérologie de l'Ouest,Institut Claudius RegaudFunder: Institut National du Cancer Project Code: INCa-7415more_vert assignment_turned_in ProjectFrom 2021Partners:INSERM, TUD, IPGP, Centre Hospitalier Universitaire de Limoges, Dresden University Biotechnology Centre +3 partnersINSERM,TUD,IPGP,Centre Hospitalier Universitaire de Limoges,Dresden University Biotechnology Centre,ANTI-INFECTIEUX : SUPPORTS MOLÉCULAIRES DES RÉSISTANCES ET INNOVATIONS THÉRAPEUTIQUES,University of Limoges,Unité Epidémiologie et modélisation de la résistance aux antimicrobiensFunder: French National Research Agency (ANR) Project Code: ANR-20-AMRB-0001Funder Contribution: 530,544 EURmore_vert
chevron_left - 1
- 2
- 3
- 4
- 5
chevron_right